On January 27, 2025, the Trump administration issued an executive order suspending U.S. foreign aid for 90 days, sparking chaos among organizations dependent on these funds. The directive, announced by Secretary of State Marco Rubio, halts nearly all aid programs pending a review of their alignment with U.S. interests. This move threatens life-saving initiatives in Africa, especially in HIV/AIDS prevention and treatment programs supported by the President’s Emergency Plan for AIDS Relief (PEPFAR).
PEPFAR, which provided antiretroviral treatment to 21 million people across 55 countries in 2024, is a critical source of funding for health services in sub-Saharan Africa. In South Africa, PEPFAR funds staff and prevention efforts at HIV clinics, while the U.S. Agency for International Development (USAID) supports broader health initiatives.
The effects are far-reaching. South African radio station, Jacaranda FM, noted that clinics such as the Wits Reproductive Health and HIV Institute and Thuthuzela Care Centres have ceased operations. These facilities provide critical services, including HIV testing, counseling, and pre-exposure prophylaxis (PrEP). The order has also affected the South African Medical Research Council, which relies on USAID for vaccine research and tuberculosis clinical trials.
The directive extends beyond health programs, freezing funds for landmine removal, refugee assistance, and counterterrorism initiatives worldwide. Critics, including Representatives Gregory Meeks and Lois Frankel, have urged immediate action to prevent deaths from interrupted treatment. Advocates fear the freeze has destabilized global humanitarian efforts, risking bankruptcy for aid groups operating on tight budgets.
While the Trump administration defends the pause as a necessary review, its consequences are dire. Without swift resolutions, millions dependent on U.S. aid in Africa and beyond face severe disruptions, jeopardizing years of progress in public health and humanitarian relief.
